Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (66)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- One virus, two clinically distinct diseases
- Schematic: Intraepithelial skin vesicle
- Reactivation begins inside a latent reservoir
- Localized zoster is usually self-limited
- Allodynia is a relevant clinical descriptor
- VZV vasculopathy: Vascular nervous-system disease
- Prevention targets two phases of VZV disease
- Selected textbook reading
Slide index & full transcript (66 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Varicella-Zoster Virus
Latency, ganglion pathology, herpes zoster, and neurologic complications
Neuropathology and clinicopathologic correlations
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning outcomes
Explain how primary VZV infection establishes neuronal latency.
Relate viral reactivation to dermatomal vesicles and radicular pain.
Recognize ganglion, peripheral nerve, and CNS complications.
Integrate morphology, clinical patterns, PCR diagnosis, and prevention.
Slide 3 · One virus, two clinically distinct diseases
Primary VZV infection
Sensory ganglion latency
Later viral reactivation
Herpes zoster
Primary infection causes chickenpox; Recurrent disease causes shingles.
Slide 4 · Chickenpox versus herpes zoster
Chickenpox
Herpes zoster
Primary infection with VZV
Generalized vesicular eruption
Often milder in healthy children
May precede years of silent latency
Reactivation of latent VZV
One or several sensory dermatomes
Often pronounced neuropathic pain
Greater burden in older or immunosuppressed patients
Slide 5 · Neural tropism explains long-term disease
VZV involves mucosal epithelium, skin, and sensory neurons.
Primary illness may resolve while viral latency persists in ganglia.
Skin eruption and neural injury can therefore occur years apart.
The recurrent rash identifies the peripheral sensory territory involved.
Slide 6 · VZV and herpes simplex: Relevant distinctions
Varicella-zoster virus
Herpes simplex viruses
Respiratory aerosol spread emphasized
Hematogenous dissemination during primary infection
Generalized chickenpox is characteristic
Infrequent symptomatic reactivation relative to HSV
Related neurotropic herpesviruses
Classically localized mucocutaneous recurrence
Also establish latency in sensory neurons
Similar intranuclear cytopathic changes
Slide 7 · From respiratory exposure to chickenpox
Respiratory infection
Systemic dissemination
Widespread skin lesions
Respiratory aerosol transmission and hematogenous spread.
Slide 8 · Primary infection is usually a systemic exanthem
Chickenpox is the clinical expression of primary VZV infection.
The skin eruption is widespread rather than segmental.
In immunocompetent children, infection is often self-limited.
Adults and immunocompromised people may experience more severe illness.
Slide 9 · Distribution is a major diagnostic clue
Primary varicella
Reactivated zoster
Lesions arise on the torso and spread to head and extremities
Multiple waves of new lesions
No single nerve territory explains the rash
Groups of vesicles in a sensory dermatome
One or several adjacent dermatomes
Pain can localize to the same nerve territory
Slide 10 · Chickenpox rash: Lesion evolution
Macule
Vesicle
Rupture / crust
Regeneration
Individual lesions progress while additional crops may appear.
Slide 11 · Chickenpox vesicles are intraepithelial
Histologically, vesicular separation is located within the epithelium.
Infected epithelial cells occur around the base of the vesicle.
Viral cytopathic changes may include intranuclear inclusions.
These are histologic features, not a substitute for viral identification.
Slide 12 · Schematic: Intraepithelial skin vesicle
Intraepithelial
Vesicle
EPIDERMIS
DERMIS
SUBCUTIS
Original schematic — not an H&E micrograph
Slide 13 · Viral inclusions: Anatomic context
Herpesvirus-infected epithelial cells may show intranuclear inclusions.
Glassy inclusions in a herpesvirus blister.
Similar nuclear changes may occur with HSV; Morphology alone is not specific.
Interpret viral cytopathic effects together with clinical findings and PCR.
Slide 14 · Why uncomplicated lesions often heal without scars
Epidermal vesiculation
Crusting
Regeneration
Intact basal epidermis
Deep destruction is not a required feature of uncomplicated chickenpox.
Slide 15 · Healing versus scar formation
Uncomplicated lesion
Trauma or superinfection
Vesicle ruptures and crusts
Epithelial repair follows
Typically no permanent scar
Additional tissue destruction can occur
Basal epidermal layer may be damaged
Residual scarring can result
Slide 16 · The end of chickenpox is not viral eradication
Cutaneous lesions resolve while VZV enters a latent state.
Latent virus is retained in peripheral sensory ganglia.
The time between primary illness and reactivation may span decades.
The subsequent disease is zoster, not a new generalized chickenpox episode.
Slide 17 · Sensory ganglia as the reservoir of latency
Ganglion cell bodies
Latency in sensory
Ganglion cells
Reactivation:
Inflammation + injury
Latent virus persists in neural tissue after skin disease resolves.
Slide 18 · Dorsal root ganglia: Important neuronal reservoir
Cell bodies of spinal sensory neurons lie in dorsal root ganglia.
VZV latency has been described in neurons and associated satellite cells.
A ganglion is anatomically linked to a defined cutaneous sensory territory.
This link provides the anatomical basis of a dermatomal recurrence.
Slide 19 · Sensory pathway: Ganglion to the skin
Spinal
Cord
Dorsal root
Ganglion
Skin /
Dermatome
Sensory neuron soma
Peripheral sensory axon
The affected ganglion connects the spinal sensory pathway to a dermatome.
Slide 20 · Trigeminal ganglia: A second major reservoir
The trigeminal system contains sensory neurons serving the face.
Reactivation in this system can produce severe zoster pain.
Trigeminal involvement is prominent among recurrent presentations.
Clinical consequences depend on the neural distribution affected.
Slide 21 · Reactivation begins inside a latent reservoir
Persistent latent VZV
Reduced immune control
Neural viral reactivation
Spread toward skin
Decreased cell-mediated immunity is suspected; Determinants are not fully understood.
Slide 22 · Cell-mediated immunity is clinically relevant
VZV persistence and clinical reactivation reflect host–virus interaction.
Robbins implicates decreased cell-mediated immune control in reactivation.
Risk rises with older age or immunosuppression.
Not every latent infection leads to clinically apparent zoster.
Slide 23 · Who is more vulnerable to zoster morbidity?
Older adults
Immunocompromised people
Reactivation and pain complications are clinically important
Postherpetic neuralgia is emphasized particularly after age 60
Recurrent episodes may occur
Reactivation may be recurrent or extensive
Neural and visceral complications are important
Disseminated infection requires particular attention
Slide 24 · Axonal spread creates a dermatome-specific eruption
Latent sensory ganglion
Spread along sensory nerve
Keratinocyte infection
Localized vesicular rash
The neural projection determines the skin territory involved.
Slide 25 · Dermatomal localization: Schematic
Other sensory territory
Other sensory territory
Affected sensory dermatome
Other sensory territory
Other sensory territory
Schematic banded organization — not an anatomical atlas
Slide 26 · Thoracic and trigeminal dermatomes are common
Thoracic segments frequently produce a unilateral truncal eruption.
Trigeminal sensory territories can produce facial zoster.
Symptoms and vesicles usually share the same distribution.
The dermatome pattern helps localize the infected sensory pathway.
Slide 27 · A generalized rash is not the same as a dermatomal rash
Generalized distribution
Segmental distribution
More characteristic of primary varicella
Crops distributed across the body
Hematogenous dissemination is central
More characteristic of reactivated zoster
Grouped vesicles follow sensory innervation
Neural transport links ganglion to skin
Slide 28 · Zoster skin lesions are more than cutaneous infection
VZV infection of keratinocytes produces vesicular lesions.
Concomitant radiculoneuritis can generate intense neuropathic pain.
Burning, sharp pain, or itching may accompany the rash.
Painful skin findings thus indicate possible sensory neural injury.
Slide 29 · Three connected components of shingles
Reactivated VZV
Sensory ganglion
Sensory axon
Radiculoneuritis
Cutaneous vesicles
Slide 30 · Localized zoster is usually self-limited
The vesicular eruption commonly resolves as infection subsides.
The course is not always free of lasting neural complications.
Persistent pain can outlast the visible skin lesions.
Older age is an important context when assessing this possibility.
Slide 31 · Affected ganglia show inflammatory destruction
Sensory ganglia may contain a dense mononuclear infiltrate.
Infected ganglion neurons can undergo cell death.
Focal necrosis and hemorrhage may accompany severe lesions.
Inflammatory injury provides a structural basis for neural dysfunction.
Slide 32 · Ganglion injury: Illustrated cellular pattern
Ganglion cell bodies
Latency in sensory
Ganglion cells
Reactivation:
Inflammation + injury
Schematic of the sensory neuronal compartment; Not a micrograph.
Slide 33 · Neuronal loss and inflammatory infiltration
Ganglion cell injury
Inflammatory response
Neuronal death can occur
Focal necrosis and hemorrhage may be present
Damaged neurons no longer maintain normal axons
Mononuclear inflammatory cells can be abundant
Inflammation involves the sensory ganglion
The process can extend into associated neural pathways
Slide 34 · Peripheral axons degenerate after neuron loss
Peripheral sensory fibers arise from ganglion neurons.
Death of the neuronal cell body can produce axonal degeneration.
Degenerating axons belonging to injured sensory neurons.
This creates a link from viral ganglionitis to persistent sensory symptoms.
Slide 35 · Neuropathic pain: A pathologic sequence
Ganglion inflammation
Sensory neuron injury
Abnormal sensory signaling
Pain / dysesthesia
The sequence illustrates clinicopathologic interpretation, not a measured pathway.
Slide 36 · Radiculoneuritis explains severe zoster pain
Pain can arise from the inflamed sensory root and associated nerve.
It may be described as burning, sharp, or intense.
Pain distribution often corresponds to the rash distribution.
Trigeminal zoster may be especially painful.
Slide 37 · Postherpetic neuralgia: Persistence after eruption
Pain can persist after the acute zoster eruption resolves.
The syndrome is especially important in people older than 60 years.
The involved sensory territory remains the clinical focus.
Persistent pain demonstrates that neural damage can outlast skin infection.
Slide 38 · Pain from active zoster versus postherpetic neuralgia
Acute zoster pain
Postherpetic neuralgia
Associated with vesicular skin disease
Radiculoneuritis accompanies active neural infection
Burning or sharp pain and itching may occur
Pain persists beyond cutaneous healing
Often more important in older adults
Stimuli ordinarily not painful may evoke pain
Slide 39 · Allodynia is a relevant clinical descriptor
Allodynia is pain evoked by a stimulus that is normally not painful.
Robbins explicitly identifies this phenomenon in postherpetic neuralgia.
It indicates abnormal sensory processing in an injured pathway.
A healed rash does not exclude ongoing neuropathic pain.
Slide 40 · Why a healed rash may leave ongoing disability
Acute sensory ganglionitis
Neuronal / axonal injury
Residual sensory dysfunction
Persistent pain syndrome
Postherpetic neuralgia is a neural complication rather than a persistent vesicular eruption.
Slide 41 · Motor weakness is possible but less common
Although VZV predominantly involves sensory ganglia, motor symptoms can occur.
Weakness may follow a distribution related to the involved segment.
Corresponding anterior horn motor neurons can be damaged.
Cranial motor nuclei may also be affected at related levels.
Slide 42 · From sensory ganglionitis to segmental weakness
Sensory ganglion inflammation
Adjacent neural structures
Segmental weakness (subset)
Motor involvement occurs in a subset; Do not assume it in every patient.
Slide 43 · Ramsay Hunt syndrome: Cranial nerve correlation
VZV can involve the geniculate ganglion region.
Associated facial nerve dysfunction may produce facial paralysis.
This is a distinctive cranial neuropathic complication of zoster.
A concurrent vesicular eruption and facial weakness should prompt consideration.
Slide 44 · Neurologic disease extends beyond sensory ganglia
VZV can cause encephalitis involving brain tissue.
Transverse myelitis can involve spinal cord tissue.
VZV vasculopathy is also a recognized complication.
These are complications, not the usual course of primary chickenpox.
Slide 45 · Neurologic complications: Site of injury
VZV-associated disease
Sensory ganglion
Peripheral nerve
Brain / spinal cord
Zoster pain
Weakness or CNS deficits
Slide 46 · Encephalitis is a documented VZV complication
Encephalitis among potential VZV manifestations.
Central nervous system involvement is especially important in susceptible hosts.
Such disease is conceptually distinct from uncomplicated dermatomal shingles.
The source does not give a VZV-specific encephalitis morphology or frequency.
Slide 47 · Transverse myelitis: Spinal cord involvement
VZV can cause inflammatory disease of the spinal cord.
Cord injury differs from peripheral sensory ganglionitis.
Clinical localization helps separate cord syndromes from radiculopathy.
Specific diagnostic criteria are not supplied in the selected Robbins excerpt.
Slide 48 · VZV vasculopathy: Vascular nervous-system disease
VZV vasculopathy is listed as a possible complication.
Vascular involvement should not be conflated with ordinary radicular pain.
The source establishes the association but gives no subtype classification.
Avoid assuming every neurologic deficit reflects ganglionitis alone.
Slide 49 · Two neurologic compartments to distinguish
Peripheral sensory system
Central nervous system
Sensory ganglion inflammation
Axonal degeneration / radiculoneuritis
Dermatomal pain, sometimes weakness
Encephalitis
Transverse myelitis
Vasculopathy affecting neurologic function
Slide 50 · Immunosuppression changes the severity spectrum
Severe primary infection and zoster may occur in immunocompromised people.
Complications can extend beyond skin and peripheral nerves.
Interstitial pneumonia and necrotizing visceral lesions.
Encephalitis, myelitis, and vasculopathy are also recognized.
Slide 51 · Beyond skin: Distribution of complicated infection
Complicated VZV
Neural tissues
Visceral tissues
Encephalitis / myelitis
Interstitial pneumonia / necrosis
Slide 52 · Host susceptibility: TLR3 is an example
Certain TLR3 mutations with greater susceptibility to VZV encephalitis.
This is a genetic susceptibility observation, not a universal mechanism.
VZV risk still depends on broader host immune competence.
The excerpt does not define a clinical genetic-testing algorithm.
Slide 53 · PCR is the primary method cited for VZV diagnosis
Polymerase chain reaction as the primary diagnostic method.
PCR detects viral nucleic acid rather than inferring the organism from morphology.
Interpret results in the context of the clinical syndrome and sampled site.
The excerpt does not specify specimen protocols, test thresholds, or sensitivities.
Slide 54 · Morphologic clues and their limitations
Finding
What it supports
What it cannot prove
Intraepithelial vesicle
Viral vesicular cytopathic injury
VZV species on its own
Intranuclear inclusions
Herpesvirus-type cell injury
VZV versus HSV identification
Ganglion neuron loss
Neural damage in zoster context
A unique cause without testing
Mononuclear ganglionitis
Inflammatory response in ganglion
Viral identity without corroboration
Slide 55 · Distinguishing VZV from HSV clinically
Evidence favoring VZV
Potential overlap with HSV
Primary generalized chickenpox history
Later painful dermatomal shingles
Latency in sensory ganglia
VZV PCR for confirmation
Both are neurotropic herpesviruses
Both may produce vesicular skin lesions
Both may cause intranuclear inclusions
Morphology alone may not distinguish the agents
Slide 56 · A practical diagnosis framework
Recognize pattern
Localize neural or cutaneous site
Consider host immune status
Use VZV PCR when indicated
Clinical interpretation remains essential; No sensitivity or algorithmic cutoff is claimed.
Slide 57 · Prevention targets two phases of VZV disease
Primary infection prevention
Reactivation complication prevention
Live attenuated varicella vaccination in childhood
Aims to prevent chickenpox and its sequelae
Exact local schedules vary
Recombinant zoster vaccination in adults over 50
Also for younger adults at increased risk
Targets zoster and related complications
Slide 58 · Vaccination relevance to neuropathology
Latent infection makes the burden of VZV extend beyond childhood.
Preventing reactivation reduces potential neural morbidity.
Postherpetic neuralgia is a particularly relevant outcome.
The selected text does not supply country-specific vaccine schedules.
Slide 59 · Clinical application: Generalized vesicles
A previously healthy child develops crops of widespread vesicular lesions after a respiratory illness. Lesions at different stages are present across the torso and extremities.
What is the most likely infection phase?
Primary varicella (chickenpox), with systemic cutaneous dissemination.
Slide 60 · Clinical application: Dermatomal pain
An older adult develops a painful band of grouped vesicles along one side of the trunk. Burning pain localizes to the same region.
What makes this a neural disorder as well as a skin disease?
Reactivated VZV travels along a sensory pathway and may cause radiculoneuritis.
Slide 61 · Clinical application: Pain after healing
After a shingles rash resolves, a person reports persistent pain when light clothing contacts the previously affected skin.
Name the key complication and sensory phenomenon.
Postherpetic neuralgia with allodynia.
Slide 62 · Clinical application: Facial paralysis
A patient with shingles develops facial weakness associated with cranial nerve-region vesicular disease.
Which named zoster-related neurologic syndrome is relevant?
Ramsay Hunt syndrome: VZV-associated facial nerve involvement.
Slide 63 · Clinical application: Immune compromise
An immunosuppressed adult with vesicular VZV disease develops systemic and neurologic symptoms rather than a limited cutaneous eruption.
What complications must be kept conceptually separate from simple zoster?
Visceral disease, encephalitis, myelitis, and vasculopathy.
Slide 64 · Integrated pathology: Skin and nervous system
Cutaneous pathology
Neural pathology
Macules evolve into intraepithelial vesicles
Viral nuclear inclusions may be present
Uncomplicated lesions crust and regenerate
Latency persists in sensory ganglia
Reactivation causes inflammatory neuronal injury
Radiculoneuritis, axonal injury, and PHN can follow
Slide 65 · Five clinicopathologic conclusions
Primary varicella and herpes zoster are two phases of one infection.
Sensory ganglion latency is the bridge between those phases.
The neural distribution determines the recurrent skin eruption.
Ganglion injury explains acute pain and possible persistent neuralgia.
PCR and preventive vaccination complement morphologic understanding.
Slide 66 · Selected textbook reading
Core reference
Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).
Relevant sections
Varicella-Zoster Virus — infections and neuropathology.
Peripheral nerve infections and viral diseases of the central nervous system.